Fufeng Group Valuation

Is 546 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 546 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 546 (HK$4.88) is trading above our estimate of fair value (HK$2.6)

Significantly Below Fair Value: 546 is trading above our estimate of fair value.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 546?

Other financial metrics that can be useful for relative valuation.

546 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue0.4x
Enterprise Value/EBITDA2.1x
PEG Ratio0.7x

Price to Earnings Ratio vs Peers

How does 546's PE Ratio compare to its peers?

The above table shows the PE ratio for 546 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average62x
9933 GHW International
213.6xn/aHK$630.0m
189 Dongyue Group
16.3x42.8%HK$12.5b
1907 China Risun Group
14.1x51.4%HK$13.2b
3983 China BlueChemical
4.1xn/aHK$10.6b
546 Fufeng Group
3.4x4.8%HK$12.3b

Price-To-Earnings vs Peers: 546 is good value based on its Price-To-Earnings Ratio (3.4x) compared to the peer average (62x).


Price to Earnings Ratio vs Industry

How does 546's PE Ratio compare vs other companies in the HK Chemicals Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a49.8%
n/an/an/a
No. of CompaniesPE048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a49.8%
n/an/an/a
No more companies

Price-To-Earnings vs Industry: 546 is good value based on its Price-To-Earnings Ratio (3.4x) compared to the Hong Kong Chemicals industry average (6.7x).


Price to Earnings Ratio vs Fair Ratio

What is 546's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

546 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio3.4x
Fair PE Ratio6.8x

Price-To-Earnings vs Fair Ratio: 546 is good value based on its Price-To-Earnings Ratio (3.4x) compared to the estimated Fair Price-To-Earnings Ratio (6.8x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 546 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentHK$4.88
HK$6.16
+26.2%
5.8%HK$6.51HK$5.80n/a2
Mar ’25HK$4.78
HK$6.16
+28.8%
5.8%HK$6.51HK$5.80n/a2
Feb ’25HK$4.30
HK$6.16
+43.2%
5.8%HK$6.51HK$5.80n/a2
Jan ’25HK$4.33
HK$6.16
+42.2%
5.8%HK$6.51HK$5.80n/a2
Dec ’24HK$4.20
HK$6.16
+46.6%
5.8%HK$6.51HK$5.80n/a2
Nov ’24HK$4.08
HK$6.16
+50.9%
5.8%HK$6.51HK$5.80n/a2
Oct ’24HK$4.41
HK$6.16
+39.6%
5.8%HK$6.51HK$5.80n/a2
Sep ’24HK$4.17
HK$6.76
+62.1%
14.2%HK$7.72HK$5.80n/a2
Aug ’24HK$4.18
HK$6.93
+65.8%
16.9%HK$8.10HK$5.76n/a2
Jul ’24HK$3.96
HK$6.93
+75.0%
16.9%HK$8.10HK$5.76n/a2
Jun ’24HK$4.25
HK$6.93
+63.1%
16.9%HK$8.10HK$5.76n/a2
May ’24HK$4.75
HK$6.93
+45.9%
16.9%HK$8.10HK$5.76n/a2
Mar ’24HK$5.23
HK$6.78
+29.7%
14.5%HK$7.77HK$5.80HK$4.782
Feb ’24HK$5.55
HK$6.78
+22.2%
14.5%HK$7.77HK$5.80HK$4.302
Jan ’24HK$4.75
HK$6.78
+42.8%
14.5%HK$7.77HK$5.80HK$4.332
Dec ’23HK$5.08
HK$6.78
+33.6%
14.5%HK$7.77HK$5.80HK$4.202
Nov ’23HK$4.15
HK$6.78
+63.5%
14.5%HK$7.77HK$5.80HK$4.082
Oct ’23HK$4.01
HK$6.78
+69.2%
14.5%HK$7.77HK$5.80HK$4.412
Sep ’23HK$4.42
HK$6.78
+53.5%
14.5%HK$7.77HK$5.80HK$4.172
Aug ’23HK$4.45
HK$5.60
+25.8%
38.8%HK$7.77HK$3.42HK$4.182
Jul ’23HK$5.03
HK$5.66
+12.6%
37.2%HK$7.77HK$3.56HK$3.962
Jun ’23HK$3.76
HK$5.66
+50.6%
37.2%HK$7.77HK$3.56HK$4.252
May ’23HK$3.97
HK$5.66
+42.6%
37.2%HK$7.77HK$3.56HK$4.752
Apr ’23HK$3.22
HK$3.80
+18.0%
5.2%HK$4.00HK$3.60HK$4.532
Mar ’23HK$3.00
HK$3.79
+26.5%
3.9%HK$3.94HK$3.65HK$5.232

Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.


Discover undervalued companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.